Old amoeba drug gets new shot at fighting deadly dengue
NCT ID NCT07016321
Summary
This study is testing whether a low-dose, repurposed drug called emetine can stop dengue fever from becoming severe or fatal. It will involve 600 hospitalized adults in Nepal who will take the drug or a placebo pill for 7 days. Researchers will monitor if the treatment reduces deaths or severe complications like organ failure over 28 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bharatpur Hospital
Bharatpur-10, Chitwan, Nepal
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Johns Hopkins University, Division of Infectious Disease
Baltimore, Maryland, 21231, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.